SequelSEC

PFIZER INC PFE

Pharmaceutical Preparations · CIK 0000078003 · Fiscal year ends 1231

Revenue
$63.70B
Fiscal year ended 2026-06-28
Operating income
Unavailable
Fiscal year ended 2026-06-28
Free cash flow
$10.98B
Fiscal year ended 2026-06-28

PFIZER INC (PFE) reported revenue of $63.70B and net income of $4.33B for the fiscal year ended 2026-06-28. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from PFIZER INC’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Pharmaceutical Preparations.

Income

PFIZER INC income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-28
Revenue$63.70B
Cost of revenue$17.08B
Gross profit$46.61B
Operating incomeUnavailable
Net income$4.33B
Research & developmentUnavailable
Weighted-average diluted sharesUnavailable
Pretax income$4.21B
Income tax expense-$164.00M
Diluted EPS$0.76
Selling, general & administrative$13.72B
General & administrativeUnavailable
Selling & marketingUnavailable

Balance

PFIZER INC balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-28
Cash & equivalents$976.00M
Total assets$201.13B
Current assets$41.36B
Total liabilities$115.64B
Current liabilities$32.65B
Total equity incl. NCI$85.49B
Temporary (mezzanine) equityUnavailable
Inventory$9.94B
Accounts receivable$12.49B
Goodwill$71.42B
Long-term debt$60.50B
Accounts payable$4.58B

Cash flow

PFIZER INC cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-28
Operating cash flow$13.40B
Capital expenditures$2.42B
Investing cash flow-$5.68B
Financing cash flow-$8.40B
Net change in cash-$661.00M
Stock-based compensation$947.00M
Common dividends paid$9.78B
Common share repurchasesUnavailable
Depreciation & amortization$6.58B

Derived

PFIZER INC derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-28
Free cash flow$10.98B
Gross margin73.2%
Operating marginUnavailable
FCF margin17.2%
SBC / revenue1.5%
Current ratio1.27x
Revenue YoY growth-0.2%
Net margin6.8%
R&D / revenueUnavailable
CapEx / revenue3.8%
Long-term debt / equity0.71x
Effective tax rate-3.9%

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open PFE in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-04View SEC filing
10-Q · Filed 2026-05-05View SEC filing
10-K · Filed 2026-02-26View SEC filing
10-Q · Filed 2025-11-04View SEC filing
10-Q · Filed 2025-08-05View SEC filing
10-Q · Filed 2025-05-05View SEC filing

Companies in the same industry

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.